Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Med Phys ; 2018 Jun 11.
Article in English | MEDLINE | ID: mdl-29888791

ABSTRACT

PURPOSE: The purpose of this study is to investigate the necessity of detruncation for scatter estimation of truncated cone-beam CT (CBCT) data and to evaluate different detruncation algorithms. Scattered radiation results in some of the most severe artifacts in CT and depends strongly on the size and the shape of the scanned object. Especially in CBCT systems the large cone-angle and the small detector-to-isocenter distance lead to a large amount of scatter detected, resulting in cupping artifacts, streak artifacts, and inaccurate CT-values. If a small field of measurement (FOM) is used, as it is often the case in CBCT systems, data are truncated in longitudinal and lateral direction. Since only truncated data are available as input for the scatter estimation, the already challenging correction of scatter artifacts becomes even more difficult. METHODS: The following detruncation methods are compared and evaluated with respect to scatter estimation: constant detruncation, cosine detruncation, adaptive detruncation, and prior-based detruncation using anatomical data from a similar phantom or patient, also compared to the case where no detruncation was performed. Each of the resulting, detruncated reconstructions serve as input volume for a Monte Carlo (MC) scatter estimation and subsequent scatter correction. An evaluation is performed on a head simulation, measurements of a head phantom and a patient using a dental CBCT geometry with a FOM diameter of 11 cm. Additionally, a thorax phantom is measured to assess performance in a C-Arm geometry with a FOM of up to 20 cm. RESULTS: If scatter estimation is based on simple detruncation algorithms like a constant or a cosine detruncation scatter is estimated inaccurately, resulting in incorrect CT-values as well as streak artifacts in the corrected volume. For the dental CBCT phantom measurement CT-values for soft tissue were corrected from -204 HU (no scatter correction) to -87 HU (no detruncation), -218 HU (constant detruncation), -141 HU (cosine detruncation), -91 HU (adaptive detruncation), -34 HU (prior-based detruncation using a different prior) and -24 HU (prior-based detruncation using the identical prior) for a reference value of -26 HU measured in slit scan mode. In all cases the prior-based detruncation results in the best scatter correction, followed by the adaptive detruncation, as these algorithms provide a rather accurate model of high-density structures outside the FOM, compared to a simple constant or a cosine detruncation. CONCLUSIONS: Our contribution is twofold: first we give a comprehensive comparison of various detruncation methods for the purpose of scatter estimation. We find that the choice of the detruncation method has a significant influence on the quality of MC-based scatter correction. Simple or no detruncation is often insufficient for artifact removal and results in inaccurate CT-values. On the contrary, prior-based detruncation can achieve a high CT-value accuracy and nearly artifact-free volumes from truncated CBCT data when combined with other state-of-the-art artifact corrections. Secondly, we show that prior-based detruncation is effective even with data from a different patient or phantom. The fact that data completion does not require data from the same patient dramatically increases the applicability and usability of this scatter estimation.

2.
Int J Mol Sci ; 18(10)2017 Sep 28.
Article in English | MEDLINE | ID: mdl-28956810

ABSTRACT

Understanding molecular interactions and regulatory mechanisms in tumor initiation, progression, and treatment response are key requirements towards advanced cancer diagnosis and novel treatment procedures in personalized medicine. Beyond decoding the gene expression, malfunctioning and cancer-related epigenetic pathways, investigations of the spatial receptor arrangements in membranes and genome organization in cell nuclei, on the nano-scale, contribute to elucidating complex molecular mechanisms in cells and tissues. By these means, the correlation between cell function and spatial organization of molecules or molecular complexes can be studied, with respect to carcinogenesis, tumor sensitivity or tumor resistance to anticancer therapies, like radiation or antibody treatment. Here, we present several new applications for bio-molecular nano-probes and super-resolution, laser fluorescence localization microscopy and their potential in life sciences, especially in biomedical and cancer research. By means of a tool-box of fluorescent antibodies, green fluorescent protein (GFP) tagging, or specific oligonucleotides, we present tumor relevant re-arrangements of Erb-receptors in membranes, spatial organization of Smad specific ubiquitin protein ligase 2 (Smurf2) in the cytosol, tumor cell characteristic heterochromatin organization, and molecular re-arrangements induced by radiation or antibody treatment. The main purpose of this article is to demonstrate how nano-scaled distance measurements between bio-molecules, tagged by appropriate nano-probes, can be applied to elucidate structures and conformations of molecular complexes which are characteristic of tumorigenesis and treatment responses. These applications open new avenues towards a better interpretation of the spatial organization and treatment responses of functionally relevant molecules, at the single cell level, in normal and cancer cells, offering new potentials for individualized medicine.


Subject(s)
Fluorescent Dyes , Microscopy, Fluorescence/methods , Molecular Imaging , Nanoparticles , Research , Biomarkers , Cell Line, Tumor , Gene Expression , Genes, Reporter , Humans , Image Interpretation, Computer-Assisted , Image Processing, Computer-Assisted , Immunohistochemistry , In Situ Hybridization, Fluorescence , Microscopy, Fluorescence/standards , Molecular Imaging/methods , Nanotechnology , Neoplasms/genetics , Neoplasms/metabolism , Neoplasms/pathology , Neoplasms/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...